ArticleCancers2024
Characterization of a Syngeneic Orthotopic Model of Cholangiocarcinoma by [
Lena Zachhuber, Thomas Filip, Behrang Mozayani, Mathilde Löbsch, Stefan Scheiner, Petra Vician, Johann Stanek, Marcus Hacker, Thomas H Helbich, Thomas Wanek and 2 more
Abstract read
In one paragraphArticle in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Lena ZachhuberPreclinical Imaging Lab (PIL), Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria.
Thomas FilipInstitute of Animal Breeding and Genetics & Biomodels Austria, University of Veterinary Medicine, 1210 Vienna, Austria.
Behrang MozayaniDepartment of Pathology, Medical University of Vienna, 1090 Vienna, Austria.
Mathilde LöbschCore Facility Laboratory Animal Breeding and Husbandry, Medical University of Vienna, 1090 Vienna, Austria.
Stefan ScheinerCentre for Cancer Research and Comprehensive Cancer Center, Division of Applied and Experimental Oncology, Medical University of Vienna, 1090 Vienna, Austria.
Petra VicianCentre for Cancer Research and Comprehensive Cancer Center, Division of Applied and Experimental Oncology, Medical University of Vienna, 1090 Vienna, Austria.
Johann StanekPreclinical Imaging Lab (PIL), Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria.
Marcus HackerDivision of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-4222-4083 Thomas H HelbichPreclinical Imaging Lab (PIL), Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-3169-778X Thomas WanekPreclinical Imaging Lab (PIL), Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-0404-4452 Walter BergerCentre for Cancer Research and Comprehensive Cancer Center, Division of Applied and Experimental Oncology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-0014-1658 Claudia KuntnerPreclinical Imaging Lab (PIL), Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-5988-1434 Funding
Gesellschaft für Forschungsfoerderung Niederoesterreich m.b.H. (GFF-NOE) LSC19-004
6 · The paper itselfAbstract
Cholangiocarcinoma (CCA) is a type of primary liver cancer originating from the biliary tract epithelium, characterized by limited treatment options for advanced cases and low survival rates. This study aimed to establish an orthotopic mouse model for CCA and monitor tumor growth using PET/MR imaging. Murine CCA cells were implanted into the liver lobe of male C57BL/6J mice. The imaging groups included contrast-enhanced (CE) MR, CE-MR with static [
Indexed as
2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG)cholangiocarcinomamagnetic resonance imaging (MRI)mouse modelorthotopicpositron emission tomography (PET)syngeneic
Identifiers
PMID39061229
PMCPMC11275149
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390